Bullous pemphigoid associated with hypereosinophilic syndrome: Simultaneous response to imatinib - 12/08/11
Freiburg, Germany
Abstract |
Hypereosinophilic syndrome is a myeloproliferative disorder defined by unexplained, persistent hypereosinophilia with cutaneous or systemic involvement. We describe a patient with coexistence of hypereosinophilic syndrome and bullous pemphigoid. Treatment with the novel tyrosine kinase inhibitor imatinib mesylate resulted in durable remission of hypereosinophilia and skin lesions.
Le texte complet de cet article est disponible en PDF.Abbreviations used : BP, DIF, HES
Plan
Funding sources: Supported in part by grants Br1475/6-3 from the German Research Council, DFG (to L. B-T.) and from the German Dermatological Society, DDG (research fellowship to S. H.). Conflicts of interest: None declared. |
Vol 56 - N° 5S
P. S68-S72 - mai 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?